Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $396.0 million.

  • Autolus Therapeutics' Total Non-Current Liabilities rose 1312.42% to $396.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.0 million, marking a year-over-year increase of 1312.42%. This contributed to the annual value of $355.0 million for FY2024, which is 3468.94% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Total Non-Current Liabilities of $396.0 million as of Q3 2025, which was up 1312.42% from $374.0 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Total Non-Current Liabilities ranged from a high of $396.0 million in Q3 2025 and a low of $92.1 million during Q4 2021
  • Its 5-year average for Total Non-Current Liabilities is $248.5 million, with a median of $244.4 million in 2023.
  • In the last 5 years, Autolus Therapeutics' Total Non-Current Liabilities skyrocketed by 939.02% in 2021 and then soared by 12300.58% in 2023.
  • Quarter analysis of 5 years shows Autolus Therapeutics' Total Non-Current Liabilities stood at $92.1 million in 2021, then soared by 107.88% to $191.5 million in 2022, then skyrocketed by 37.64% to $263.6 million in 2023, then surged by 34.69% to $355.0 million in 2024, then increased by 11.56% to $396.0 million in 2025.
  • Its Total Non-Current Liabilities was $396.0 million in Q3 2025, compared to $374.0 million in Q2 2025 and $374.8 million in Q1 2025.